top of page

Editas Medicine and Beam Therapeutics are rumored to be close to a deal.

  • Aug 6, 2020
  • 1 min read

Updated: Sep 9, 2020


ree

Editas Medicine and Beam Therapeutics, two firms working on CRISPR gene editor technology, are rumored to be close to a deal. Both firms shot up over 20% today in trading, despite both firms declining to comment on the issue.


 
 
 

Comments

bottom of page